| Date | Time | Source | Headline | Symbol | Company |
| 01/16/2007 | 9:31AM | PR Newswire (US) | Seven Summits Research releases comments on CSCO, GE, AMD, HOG and FRX | NYSE:FRX | Forest Road Acquisition Corp |
| 01/16/2007 | 8:05AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Q3'07 Diluted Earnings Per Share of $0.78 | NYSE:FRX | Forest Road Acquisition Corp |
| 01/11/2007 | 4:03PM | PR Newswire (US) | Forest Laboratories Announces Completion of Acquisition of Cerexa, Inc. | NYSE:FRX | Forest Road Acquisition Corp |
| 01/05/2007 | 8:55AM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2007 Third Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 12/14/2006 | 9:07AM | PR Newswire (US) | Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment | NYSE:FRX | Forest Road Acquisition Corp |
| 12/14/2006 | 8:29AM | PR Newswire (US) | Forest Laboratories Announces Acquisition of Cerexa, Inc. | NYSE:FRX | Forest Road Acquisition Corp |
| 12/06/2006 | 8:00AM | PR Newswire (US) | Lexapro(R) Demonstrated Significance on Prospectively Defined Efficacy Parameter and Was Better Tolerated Than Cymbalta(R) in Tr | NYSE:FRX | Forest Road Acquisition Corp |
| 12/01/2006 | 11:51AM | PR Newswire (US) | Seven Summits Research Releases Comments on GS, MCD, UAUA, FRX, and GPS | NYSE:FRX | Forest Road Acquisition Corp |
| 10/28/2006 | 12:08AM | PR Newswire (US) | Patient Recruitment to Resume Without Modification of Protocol for Desmoteplase Phase IIB/III Stroke Study DIAS-2 | NYSE:FRX | Forest Road Acquisition Corp |
| 10/28/2006 | 12:08AM | PR Newswire (US) | Patient Recruitment to Resume Without Modification of Protocol for Desmoteplase Phase IIB/III Stroke Study DIAS-2 | NYSE:FRX | Forest Road Acquisition Corp |
| 10/25/2006 | 9:52AM | PR Newswire (US) | Patient Recruitment for Desmoteplase Phase IIB/III Stroke Study DIAS-2 Placed on Hold | NYSE:FRX | Forest Road Acquisition Corp |
| 10/23/2006 | 8:00AM | PR Newswire (US) | U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem | NYSE:FRX | Forest Road Acquisition Corp |
| 10/17/2006 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on JNJ, EMC, FRX, UTX, and ODP | NYSE:FRX | Forest Road Acquisition Corp |
| 10/17/2006 | 8:57AM | PR Newswire (US) | Forest Laboratories Reports Earnings Per Share of $0.75 for Q2'07 | NYSE:FRX | Forest Road Acquisition Corp |
| 10/05/2006 | 5:51PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2007 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 09/07/2006 | 9:00AM | PR Newswire (US) | Forest Laboratories Inc. Announces Appointment of Dr. Lawrence S. Olanoff as President and Chief Operating Officer | NYSE:FRX | Forest Road Acquisition Corp |
| 07/18/2006 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on HPQ, KO, UTX, FRX, and USB | NYSE:FRX | Forest Road Acquisition Corp |
| 07/18/2006 | 8:58AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal First Quarter 2007 Results | NYSE:FRX | Forest Road Acquisition Corp |
| 07/13/2006 | 9:05PM | PR Newswire (US) | Forest Announces Federal Court Upholds Lexapro(R) Patent | NYSE:FRX | Forest Road Acquisition Corp |
| 07/11/2006 | 9:55AM | PR Newswire (US) | Forest Laboratories, Inc. and H. Lundbeck A/S File Lawsuit Against Caraco Pharmaceutical Laboratories, Ltd. for Patent Infringe | NYSE:FRX | Forest Road Acquisition Corp |
| 07/10/2006 | 3:14PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call For Fiscal 2007 First Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 05/18/2006 | 4:02PM | PR Newswire (US) | /C O R R E C T I O N -- Forest Laboratories, Inc./ | NYSE:FRX | Forest Road Acquisition Corp |
| 05/18/2006 | 3:26PM | PR Newswire (US) | Forest Laboratories Announces Nesli Basgoz, M.D. Named to Board of Directors | NYSE:FRX | Forest Road Acquisition Corp |
| 05/18/2006 | 3:25PM | PR Newswire (US) | Forest Laboratories, Inc. Announces New Share Repurchase Program | NYSE:FRX | Forest Road Acquisition Corp |
| 04/25/2006 | 12:18PM | PR Newswire (US) | Seven Summits Research Releases Comments on OXY, FRX, WHR, COH, and BNI | NYSE:FRX | Forest Road Acquisition Corp |
| 04/25/2006 | 9:07AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Q4'06 Diluted Earnings Per Share of $0.28 Including $0.37 Per Share Charge for Licensing and | NYSE:FRX | Forest Road Acquisition Corp |
| 04/12/2006 | 5:05PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2006 Fourth Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 04/10/2006 | 9:00AM | PR Newswire (US) | Forest and Almirall Announce a Development and Marketing Collaboration Agreement on New Therapy for COPD | NYSE:FRX | Forest Road Acquisition Corp |
| 03/02/2006 | 8:30AM | PR Newswire (US) | Forest Laboratories Receives Patent Term Extension for Lexapro | NYSE:FRX | Forest Road Acquisition Corp |
| 02/23/2006 | 8:35AM | PR Newswire (US) | Replidyne and Forest Laboratories Announce FDA Acceptance for Review of New Drug Application for Oral Antibiotic Faropenem Medox | NYSE:FRX | Forest Road Acquisition Corp |